Prevalence of COVID-19 in patients with autoimmune liver disease in Europe: A patient-oriented online survey

Hepatology

Metabolic associated fatty liver disease increases COVID-19 disease severity in non-diabetic patients

J Gastroenterol Hepatol.

Gao F, Zheng KI, Wang XB, Yan HD, Sun QF, Pan KH, Wang TY, Chen YP, George J, Zheng MH

doi: 10.1111/jgh.15112.

Further Publications

AGA Institute Rapid Review of the GI and Liver Manifestations of COVID-19, Meta-Analysis of International Data, and Recommendations for the Consultative Management of Patients with COVID-19

Gastroenterology.

Sultan S, Altayar O, Siddique SM, Davitkov P, Feuerstein JD, Lim JK, Falck-Ytter Y, El-Serag HB, AGA.

doi: 10.1053/j.gastro.2020.05.001.

Hepatology

Liver Biochemistries in Hospitalized Patients With COVID-19

Hepatology.

Bloom PP, Meyerowitz EA, Reinus Z, Daidone M, Gustafson J, Kim AY, Schaefer E, Chung RT

doi: 10.1002/hep.31326.

Further Publications

Predictors of Outcomes of COVID-19 in Patients with Chronic Liver Disease: US Multi-center Study

Clin Gastroenterol Hepatol

Kim D, Adeniji N, Latt N, Kumar S, Bloom PP, Aby ES, Perumalswami P, Roytman M, Li M, Vogel AS, Catana AM, Wegermann K, Carr RM, Aloman C, Chen V, Rabiee A, Sadowski B, Nguyen V, Dunn W, Chavin K, Zhou K, Lizaola-Mayo B, Moghe A, Debes J, Lee TH, Branch A, Viveiros K, Chan W, Chascsa D, Kwo P, Dhanasekaran R

doi: 10.1016/j.cgh.2020.09.027

Inflammatory Bowel Disease

Impact of COVID-19 pandemic on the daily management of biotechnological therapy in inflammatory bowel disease patients: Reorganisational response in a high-volume Italian inflammatory bowel disease centre

United European Gastroenterol J.

Scaldaferri F, Pugliese D, Privitera G, Onali S, Lopetuso LR, Rizzatti G, Settanni CR, Pizzoferrato M, Schiavoni E, Turchini L, Amatucci V, Napolitano D, Bernabei T, Mora V, Laterza L, Papa A, Guidi L, Rapaccini GL, Gasbarrini A, Armuzzi A

doi: 10.1177/2050640620929133.

Inflammatory Bowel Disease

Management of COVID-19 Pandemic in Spanish Inflammatory Bowel Disease Units: Results From a National Survey

Inflamm Bowel Dis.

Martin Arranz E, Suarez Ferrer C, García Ramírez L, Rueda García JL, Sánchez-Azofra M, Poza Cordón J, Noci J, Zabana Y, Barreiro-de Acosta M, Martín-Arranz MD

doi: 10.1093/ibd/izaa142.

Hepatology

SARS-CoV-2 infection of the liver directly contributes to hepatic impairment in patients with COVID-19

J Hepatol.

Wang Y, Liu S, Liu H, Li W, Lin F, Jiang L, Li X, Xu P, Zhang L, Zhao L, Cao Y, Kang J, Yang J, Li L, Liu X, Li Y, Nie R, Mu J, Lu F, Zhao S, Lu J, Zhao J

doi: 10.1016/j.jhep.2020.05.002.

Hepatology

Liver injury is associated with severe Coronavirus disease 2019 (COVID-19) infection: a systematic review and meta-analysis of retrospective studies

Hepatol Res.

Parohan M, Yaghoubi S, Seraj A

doi: 10.1111/hepr.13510.

Hepatology

Perioperative Presentation of COVID-19 Disease in a Liver Transplant Recipient

Hepatology.

Qin J, Wang H, Qin X, Zhang P, Zhu L, Cai J, Yuan Y, Li H

doi: 10.1002/hep.31257.

Related content

Metabolic associated fatty liver disease increases COVID-19 disease severity in non-diabetic patients

AGA Institute Rapid Review of the GI and Liver Manifestations of COVID-19, Meta-Analysis of International Data, and Recommendations for the Consultative Management of Patients with COVID-19

Liver Biochemistries in Hospitalized Patients With COVID-19

Predictors of Outcomes of COVID-19 in Patients with Chronic Liver Disease: US Multi-center Study

Impact of COVID-19 pandemic on the daily management of biotechnological therapy in inflammatory bowel disease patients: Reorganisational response in a high-volume Italian inflammatory bowel disease centre

Management of COVID-19 Pandemic in Spanish Inflammatory Bowel Disease Units: Results From a National Survey

SARS-CoV-2 infection of the liver directly contributes to hepatic impairment in patients with COVID-19

Liver injury is associated with severe Coronavirus disease 2019 (COVID-19) infection: a systematic review and meta-analysis of retrospective studies

Perioperative Presentation of COVID-19 Disease in a Liver Transplant Recipient